Omegga GmbH

Omegga GmbH, based in Germany, specializes in innovative poultry technology, focusing on a sustainable approach through an advanced machine learning solution for In-Ovo sexing of chicken embryos, enhancing operational efficiencies for hatcheries. Founded in 2020 by Paul Kiok, Omegga GmbH operates out of München, Germany, and focuses on developing technologies for the poultry industry. The company has secured a total of 3 deals, with its most recent funding round, a Seed round, raising EUR 10. 000 mn from investors including Capnamic, European Innovation Council, and IQ Capital.

Omegga's founder has not been specified, and there are no details regarding any pivots or changes in business strategy. Omegga specializes in pioneering sustainable poultry technologies, focusing primarily on an innovative, non-invasive method for In-Ovo sexing of chicken embryos. This machine learning-based solution allows hatcheries to determine the sex of embryos early in the incubation process, significantly reducing the resource-intensive rearing of male chicks, which currently results in substantial financial losses. The core offering targets poultry producers, enabling them to align with evolving regulatory demands and consumer preferences regarding the humane treatment of male chicks, thereby promoting sustainability within the industry.

The technology is designed to meet the needs of hatcheries globally, with planned large-scale industrial testing set for 2024, followed by anticipated market availability in Germany in 2025. The revenue model for Omegga relies on B2B transactions, wherein poultry producers and hatcheries are the primary clients. The company is expected to engage in partnerships and collaborations with these producers, offering its In-Ovo sexing technology as a service to enhance operational efficiencies. The financial structure for these transactions typically involves agreements that may encompass installation fees, ongoing service charges, and potential performance-based incentives linked to the successful implementation of the technology.

Omegga's focus on delivering a solution that addresses both economic and ethical dimensions of poultry production is anticipated to create a favorable revenue stream, particularly as legislation around chick culling becomes more stringent and consumer demand for humane practices increases. The February 2026 funding will be utilized by the company to scale commercialization of its AI‑driven in‑ovo sexing platform, expand manufacturing and deployment capabilities, and deepen partnerships with hatcheries. It also aims to accelerate product development, broaden application use cases, and strengthen its market presence across Europe while addressing regulatory and operational requirements in poultry production.